First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing

BACKGROUND: The Centers for Disease Control and Prevention state that a severe or immediate allergic reaction to the first dose of an mRNA COVID-19 vaccine is a contraindication for the second dose. OBJECTIVE: To assess outcomes associated with excipient skin testing after a reported allergic reacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolfson, Anna R., Robinson, Lacey B., Li, Lily, McMahon, Aubree E., Cogan, Amelia S., Fu, Xiaoqing, Wickner, Paige, Samarakoon, Upeka, Saff, Rebecca R., Blumenthal, Kimberly G., Banerji, Aleena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217699/
https://www.ncbi.nlm.nih.gov/pubmed/34166844
http://dx.doi.org/10.1016/j.jaip.2021.06.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217699/
https://www.ncbi.nlm.nih.gov/pubmed/34166844
http://dx.doi.org/10.1016/j.jaip.2021.06.010

Ejemplares similares